MCLEAN, Va.--(BUSINESS WIRE)--Perthera, the premier personalized medicine service company, today announced that it is a finalist in the bioscience category of the Virginia Velocity business plan competition. Sponsored by Governor Terry McAuliffe and overseen by the Office of the Secretary of Commerce and Trade, the Virginia Velocity awards focus on recognizing outstanding entrepreneurs in the state who are building success through innovation in key strategic growth sectors such as bioscience and energy.
“We are extremely excited and honored to receive such a great testimonial of support for our strategic business plan, which is based ultimately around our mission of extending and saving lives,” said Andrew Mignatti, president & CEO of Perthera. “Personalized medicine is a rapidly growing industry and Perthera is uniquely positioned as both a service provider and a data analytics firm that delivers best-in-class, comprehensive, personalized cancer therapy options.”
The four finalists were selected by independent judges and two rounds of competition. Perthera is one of two finalists in the bioscience category and will now compete in a final competition round for a cash award of $800,000. Winners will be announced next Tuesday, Sept. 8, at CenterStage in Richmond, Virginia.
About Perthera
Perthera, based in McLean, Va, is the premier personalized medicine service company. As the only organization to combine the latest multi-omic molecular profiling, including genomic, proteomic and phosphoproteomic analysis, with a patient's medical history and state-of-the-art diagnostic technology, Perthera enables oncologists to deliver precision medicine to treat an individual patient's unique cancer. For more information, visit us on www.perthera.com, Twitter, Facebook and YouTube.
